A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications.
Clinical trial NCT04179409 · COMPLETED
Trial details
- NCT number
- NCT04179409
- Sponsor
- Kevin Flanigan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-18
- Primary completion
- 2021-09-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.